Skip to main content
All vulnerabilities
CVE-2023-38950

ZKTeco BioTime Path Traversal Vulnerability

ZKTeco — BioTime

EPSS (30-day exploitation probability)
92.5% · 99.8th percentile · 20 November 2026
Added to KEV catalog
19 May 2025
Federal remediation due date
9 June 2025
Weakness classification (CWE)
CWE-22

Is CVE-2023-38950 actively exploited?

Yes. CISA added CVE-2023-38950 to its Known Exploited Vulnerabilities catalog on 19 May 2025, which means there is evidence it has been exploited in the wild. FIRST's EPSS model estimates a 92.5% probability of exploitation activity in the next 30 days, placing it in the 99.8th percentile of all scored CVEs.

How do I fix CVE-2023-38950?

CISA's required action for CVE-2023-38950 is: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable. US federal agencies must remediate it by 9 June 2025; treat that as an outside deadline, not a target.

CISA Description

ZKTeco BioTime contains a path traversal vulnerability in the iclock API that allows an unauthenticated attacker to read arbitrary files via supplying a crafted payload.

Required action

Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

Notes

https://www.zkteco.com/en/Security_Bulletinsibs ; https://nvd.nist.gov/vuln/detail/CVE-2023-38950

Confirm Your Exposure

Is this vulnerability present in your environment?

CRS delivers independent VAPT assessments that identify exactly which known-exploited vulnerabilities exist in your network, applications, and infrastructure.

Explore VAPT Services